These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
283 related articles for article (PubMed ID: 12365018)
1. Parathyroid hormone-related protein measured at the time of first visit is an indicator of bone metastases and survival in lung carcinoma patients with hypercalcemia. Hiraki A; Ueoka H; Bessho A; Segawa Y; Takigawa N; Kiura K; Eguchi K; Yoneda T; Tanimoto M; Harada M Cancer; 2002 Oct; 95(8):1706-13. PubMed ID: 12365018 [TBL] [Abstract][Full Text] [Related]
2. Tumor-induced hypercalcemia and parathyroid hormone-related protein in lung carcinoma. Takai E; Yano T; Iguchi H; Fukuyama Y; Yokoyama H; Asoh H; Ichinose Y Cancer; 1996 Oct; 78(7):1384-7. PubMed ID: 8839542 [TBL] [Abstract][Full Text] [Related]
3. [Survival status of stage IV non-small cell lung cancer patients after radiotherapy--a report of 287 cases]. Cai Y; Wang WL; Xu B; Zhu GY; Zhang SW Ai Zheng; 2006 Nov; 25(11):1419-22. PubMed ID: 17094913 [TBL] [Abstract][Full Text] [Related]
4. [The value of the parathyrin-related protein (PTH-RP) in the diagnosis of cancer-associated hypercalcemia]. Sagarra E; Villabona C; Bonnin R; Moliner R; Merino FJ; Sahún M; Soler J Med Clin (Barc); 1995 Oct; 105(12):450-4. PubMed ID: 7490935 [TBL] [Abstract][Full Text] [Related]
5. Serum parathyroid hormone-related peptide is associated with systemic inflammation and adverse prognosis in gastroesophageal carcinoma. Deans C; Wigmore S; Paterson-Brown S; Black J; Ross J; Fearon KC Cancer; 2005 May; 103(9):1810-8. PubMed ID: 15800880 [TBL] [Abstract][Full Text] [Related]
7. Prognostic value of carcinoembryonic antigen and CYFRA21-1 in patients with pathological stage I non-small cell lung cancer. Matsuoka K; Sumitomo S; Nakashima N; Nakajima D; Misaki N Eur J Cardiothorac Surg; 2007 Sep; 32(3):435-9. PubMed ID: 17611117 [TBL] [Abstract][Full Text] [Related]
8. Chinese hamster ovarian cells transfected with human parathyroid hormone-related protein cDNA cause hypercalcemia in nude mice. Guise TA; Chirgwin JM; Favarato G; Boyce BF; Mundy GR Lab Invest; 1992 Oct; 67(4):477-85. PubMed ID: 1434529 [TBL] [Abstract][Full Text] [Related]
9. Contribution of parathyroid hormone-related peptide to the evaluation of hypercalcemia. Audran M; Minebois-Villégas A; Lortholary A; Legrand E; Pascaretti C; Giraud P; Subra JF; Boasson M; Jallet P Rev Rhum Engl Ed; 1995 Mar; 62(3):189-96. PubMed ID: 7788336 [TBL] [Abstract][Full Text] [Related]
10. Hypercalcemic complication in patients with oral squamous cell carcinoma. Iwase M; Takemi T; Manabe M; Nagumo M Int J Oral Maxillofac Surg; 2003 Apr; 32(2):174-80. PubMed ID: 12729778 [TBL] [Abstract][Full Text] [Related]
11. Bone turnover markers as predictors of skeletal complications in prostate cancer, lung cancer, and other solid tumors. Brown JE; Cook RJ; Major P; Lipton A; Saad F; Smith M; Lee KA; Zheng M; Hei YJ; Coleman RE J Natl Cancer Inst; 2005 Jan; 97(1):59-69. PubMed ID: 15632381 [TBL] [Abstract][Full Text] [Related]
12. Risk factors for skeletal-related events in patients with non-small cell lung cancer treated by chemotherapy. Sekine I; Nokihara H; Yamamoto N; Kunitoh H; Ohe Y; Tamura T Lung Cancer; 2009 Aug; 65(2):219-22. PubMed ID: 19081161 [TBL] [Abstract][Full Text] [Related]
13. Postoperative serum carcinoembryonic antigen levels in patients with pathologic stage IA nonsmall cell lung carcinoma: subnormal levels as an indicator of favorable prognosis. Sawabata N; Maeda H; Yokota S; Takeda S; Koma M; Tokunaga T; Ito M Cancer; 2004 Aug; 101(4):803-9. PubMed ID: 15305413 [TBL] [Abstract][Full Text] [Related]
14. Serum protein expression predicts recurrence in patients with early-stage lung cancer after resection. D'Amico TA; Brooks KR; Joshi MB; Conlon D; Herndon J; Petersen RP; Harpole DH Ann Thorac Surg; 2006 Jun; 81(6):1982-7; discussion 1987. PubMed ID: 16731117 [TBL] [Abstract][Full Text] [Related]
15. Hypercalcemia of malignancy: a study of clinical features and relationships among circulating levels of calcium, parathyroid hormone and parathyroid hormone-related peptide. Sriussadaporn S; Phoojaroenchanachai M; Ploybutr S; Plengvidhya N; Peerapatdit T; Nitiyanant W; Vannasaeng S; Vichayanrat A J Med Assoc Thai; 2007 Apr; 90(4):663-71. PubMed ID: 17487119 [TBL] [Abstract][Full Text] [Related]
16. Distribution according to histologic type and outcome by gender and age group in Taiwanese patients with lung carcinoma. Chen KY; Chang CH; Yu CJ; Kuo SH; Yang PC Cancer; 2005 Jun; 103(12):2566-74. PubMed ID: 15852359 [TBL] [Abstract][Full Text] [Related]
17. Extrapulmonary small-cell carcinoma compared with small-cell lung carcinoma: a retrospective single-center study. Cicin I; Karagol H; Uzunoglu S; Uygun K; Usta U; Kocak Z; Caloglu M; Saynak M; Tokatli F; Uzal C Cancer; 2007 Sep; 110(5):1068-76. PubMed ID: 17614337 [TBL] [Abstract][Full Text] [Related]
18. Prognostic factors for patients with spinal metastases from lung cancer. Ogihara S; Seichi A; Hozumi T; Oka H; Ieki R; Nakamura K; Kondoh T Spine (Phila Pa 1976); 2006 Jun; 31(14):1585-90. PubMed ID: 16778693 [TBL] [Abstract][Full Text] [Related]
19. Effect of histologic type and smoking status on interpretation of serum carcinoembryonic antigen value in non-small cell lung carcinoma. Okada M; Nishio W; Sakamoto T; Uchino K; Yuki T; Nakagawa A; Tsubota N Ann Thorac Surg; 2004 Sep; 78(3):1004-9; discussion 1009-10. PubMed ID: 15337038 [TBL] [Abstract][Full Text] [Related]
20. The prognostic value of carcinoembryonic antigen in T1N1M0 and T2N1M0 non-small cell carcinoma of the lung. Fukai R; Sakao Y; Sakuraba M; Oh S; Shiomi K; Sonobe S; Saitoh Y; Miyamoto H Eur J Cardiothorac Surg; 2007 Sep; 32(3):440-4. PubMed ID: 17643308 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]